COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce.

Favara, D M; Cooke, A; Doffinger, R; McAdam, K; Corrie, P; Ainsworth, N L

Favara, D M; Cooke, A; Doffinger, R; McAdam, K; Corrie, P; Ainsworth, N L.

Favara DM; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Oncology, The Queen Elizabeth Hospital, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, Kings Lynn, UK; Department of Oncology, University of Cambridge, Ca
Cooke A; Cambridge Clinical Laboratories, Cambridge, UK.
Doffinger R; Department of Immunology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
McAdam K; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Oncology, Peterborough City Hospital, North West Anglia NHS Foundation Trust, Peterborough, UK.
Corrie P; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Ainsworth NL; Department of Oncology, The Queen Elizabeth Hospital, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, Kings Lynn, UK.

Clin Oncol (R Coll Radiol) ; 33(1): e61-e63, 2021 Jan.

Article in English | MEDLINE | ID: covidwho-676124

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Clin Oncol (R Coll Radiol) Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.clon.2020.07.015

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google